Cell Biology for Boron Neutron Capture Therapy (BNCT)
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 30 September 2024 | Viewed by 248
Special Issue Editors
2. Neutron Therapy Research Center, Okayama University, Okayama 700-8530, Japan
3. German Society for Boron Neutron Capture Therapy, 45122 Essen, Germany
Interests: radiation oncology; hadron therapy; boron neutron capture therapy (BNCT); neutrons; high-LET radiation; radiation biology; eye tumors; ophthalmic oncology
Special Issues, Collections and Topics in MDPI journals
2. Visiting Scientist, Central Radioisotope Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
Interests: radiation oncology; biology in anti-cancer treatment; polyADP-ribosylation; anti-tumor therapeutic; mouse; boron neutron capture therapy
Special Issues, Collections and Topics in MDPI journals
Interests: cancer biology; imaging; BNCT; elemental imaging; activable X-ray nanodrugs; theranostic compounds
Special Issues, Collections and Topics in MDPI journals
Interests: clinically oriented radiation biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear colleagues,
The emergence of epithermal neutron sources in hospitals has made boron neutron capture therapy (BNCT) a focus of innovative developments in radiation oncology.
Given the rapid progress in clinical and preclinical research on BNCT, we invite contributions for this Special Issue of Cells in the form of original research articles and reviews on all cellular aspects related to BNCT.
Relevant topics include, but are not limited to, the following:
- Radiation biology for BNCT;
- Cell-based studies;
- Drug development for BNCT;
- Impact of BNCT on the proteomic profile and omics approaches;
- Boron imaging;
- Mechanisms of action of BNCT;
- Immunological aspects, including abscopal effect of BNCT;
- Biomarkers for therapeutic optimization.
Prof. Dr. Wolfgang Sauerwein
Prof. Dr. Mitsuko Masutani
Prof. Dr. Lucie Sancey
Prof. Dr. John Hopewell
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- boron neutron capture therapy (BNCT)
- radiation biology
- radiation oncology
- drug development
- imaging
- targeted therapies
- boron chemistry
Related Special Issues
- Biology of Boron Neutron Capture Therapy (BNCT) 2021 in Cells (4 articles)
- Biology of Boron Neutron Capture Therapy (BNCT) in Cells (10 articles)
- BNCT Drug Development and Preclinical Testing in Cells (5 articles)
